If your research is in life, physical or medical sciences, you might be able to develop your idea with funding from other UCL sources.
UCL Business (UCLB) can help you access funding both from within the organisation and beyond. This includes two significant funds.
UCL Technology Fund
This £53 million fund invests in opportunities to commercialise intellectual property. Its focus is on the physical and life sciences.
The fund is jointly managed by UCLB and Albion Capital, who’ll work with you to support your application.
You can use the funding to:
- prove your concept
- improve licensing outcomes
- support spinout companies
Apollo Therapeutics Fund
This fund is a collaboration between three pharmaceutical companies (AstraZeneca, GlaxoSmithKline and Johnson & Johnson) and the technology transfer offices of UCL, Imperial College London and the University of Cambridge.
The £40 million fund supports early stage biomedical projects that could have a real impact on patient treatments and outcomes.
UCL Translational Research Office
The UCL Translational Research Office (TRO) helps to translate research into therapies, techniques and medicinal products with therapeutic value.
One of the funding opportunities available through TRO is the UCL Therapeutic Acceleration Support Fund. It aims to speed up the transition from discovery to the early stages of therapeutic development by supporting initial translational work.